Reliq Health Technologies, Inc. Announces 34 New Acute and Long-Term Care Hospital Clients and Upcoming Shareholder Update Webinar
January 06 2023 - 3:01AM
Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or
WKN:A2AJTB) (“
Reliq” or the
“
Company”), a rapidly growing global healthcare
technology company that develops innovative Virtual Care solutions
for the multi-billion dollar Healthcare market, is pleased to
announce that it has added 34 new acute and long-term care hospital
clients to a previously disclosed contract with a large healthcare
network in Florida. These new clients are expected to add over
20,000 patients per year to Reliq’s iUGO Care platform at an
average revenue of $65 per patient per month. The Company also
wishes to invite shareholders to attend a webinar on Wednesday,
January 11, 2023 at 9:00am PST / 12:00pm EST, where the Company
will provide an update on operations and discuss the outlook for
2023.
“The biggest risk to profit margins for acute
and long term care hospitals is the potential for patient
readmissions within the first 30 days after discharge,” said Dr.
Lisa Crossley, CEO at Reliq Health Technologies, Inc. “The Centers
for Medicare & Medicaid Services (CMS) assess financial
penalties to hospitals under the Hospital Readmissions Reduction
Program (HRRP) based on rates of readmission. In 2021, 96% of all
hospitals in Florida received a financial penalty due to
readmission rates (www.cms.gov). We have consistently demonstrated
that patients who are monitored using our iUGO Care platform have
better health outcomes and lower rates of hospital admissions and
readmissions, which can significantly reduce or eliminate HRRP
penalties for our clients. We are excited to be working with these
hospitals which specialize in cardiac and orthopedic patients to
help improve post-discharge outcomes for patients who have
experienced cardiac events (acute myocardial infarction, heart
failure), cardiac surgery (“bypass”) or orthopedic surgery (hip or
knee replacement). We expect to add approximately 1,700 patients
per month to our platform from these clients, or over 20,000
patients per year with revenues of $65 per patient per month at 75%
gross margin.”
“We are also pleased to invite shareholders to
attend a webinar on Wednesday, January 11th to discuss the outlook
for 2023 and provide a detailed update on operations,” continued
Dr. Crossley. “Log-in details for the webinar are provided
below.”
Webinar Login Information:
|
Date: |
January 11,
2023 |
|
Time: |
9:00am PST / 12:00pm EST |
|
URL: |
www.reliqhealth.com/webinar |
For those who are not able to attend the
webinar, a recording will be available on the Company’s website
(www.reliqhealth.com) shortly after the webinar concludes.
Reliq Health
Reliq Health Technologies is a rapidly growing
global healthcare technology company that specializes in developing
innovative Virtual Care solutions for the multi-billion dollar
Healthcare market. Reliq’s powerful iUGO Care platform supports
care coordination and community-based virtual healthcare. iUGO Care
allows complex patients to receive high quality care at home,
improving health outcomes, enhancing quality of life for patients
and families and reducing the cost of care delivery. iUGO Care
provides real-time access to remote patient monitoring data,
allowing for timely interventions by the care team to prevent
costly hospital readmissions and ER visits. Reliq Health
Technologies trades on the TSX Venture under the symbol RHT, on the
OTC as RQHTF and on the Frankfurt Stock Exchange under the
WKN:A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company ContactInvestor Relations at
ir@reliqhealth.com
US Investor Relations ContactInvestor
RelationsLytham Partners, LLCBen ShamsianNew York |
Phoenix646-829-9701shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward
Looking Information
Certain statements in this press release
constitute forward-looking statements, within the meaning of
applicable securities laws. All statements that are not historical
facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives,
assumptions, expectations or beliefs of future performance, are
"forward-looking statements".
We caution you that such "forward-looking
statements" involve known and unknown risks and uncertainties that
could cause actual and future events to differ materially from
those anticipated in such statements.
Forward-looking statements include, but are not
limited to, statements with respect to commercial operations,
including technology development, anticipated revenues, projected
size of market, and other information that is based on forecasts of
future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the
"Company") does not intend and does not assume any
obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology
development and marketing activities, the Company's historical
experience with technology development, uninsured risks. Actual
results may differ materially from those expressed or implied by
such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Jul 2023 to Jul 2024